Medwest
ActiveMedwest has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €937k and a net result of €190k. Equity is growing by ~14% per year across the filed fiscal years. Its solvency ranks better than 85% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
96
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability92▲+1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €85k at 30 days acceptable
Liquidity ample (current ratio 16.92 against 15.26 in 2024; short-term debt: 4.2% and cash: 31.6% of total assets), and 9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
91%
Return on assets
18.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
9 d early
2024
35 d late
2023
31 d late
2022
31 d late
2021
31 d late
2020
30 d late
2019
92 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€937k▲ 13.3%
2024 · €827k
2018: €317k
2019: €398k
2020: €445k
2021: €578k
2022: €657k
2023: €723k
2024: €827k
2018 → 2025
Total assets
€1.03M▲ 8.0%
2024 · €953k
2018: €656k
2019: €695k
2020: €712k
2021: €810k
2022: €860k
2023: €905k
2024: €953k
2018 → 2025
Net result
€190k▲ 14.2%
2024 · €167k
2018: €83k
2019: €80k
2020: €114k
2021: €132k
2022: €148k
2023: €150k
2024: €167k
2018 → 2025
Working capital
€694k▲ 16.1%
2024 · €598k
2018: €81k
2019: €202k
2020: €238k
2021: €389k
2022: €476k
2023: €480k
2024: €598k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€578k-€657k▲ 13.7%€723k▲ 10.1%€827k▲ 14.4%€937k▲ 13.3%
Operating result€206k-€214k▲ 3.9%€245k▲ 14.3%€245k▼ 0.2%€252k▲ 2.9%
Net result€132k-€148k▲ 11.8%€150k▲ 1.4%€167k▲ 11.1%€190k▲ 14.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 3% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.03M
Fixed assets
€292k▼ 6.9%
Current assets
€738k▲ 15.3%
Equity and liabilities €1.03M
Equity
€937k▲ 13.3%
Debt
€92k▼ 26.7%
The debt ratio falls from 13.2% to 9.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€305k▲
2024 · €296k
Cash flow
€243k▲
2024 · €218k
Solvency
91.0%▲
2024 · 86.8%
Current ratio
16.92▲
2024 · 15.26
Quick ratio
16.92▲
2024 · 15.26
Debt / equity
0.10▼
2024 · 0.15
ROE
20.3%▲
2024 · 20.2%
ROA
18.5%▲
2024 · 17.5%
Interest coverage
59.75▲
2024 · 15.24
Debt
€92k▼
2024 · €126k
Debt ≤ 1 year
€44k▲
2024 · €42k
Debt > 1 year
€49k▼
2024 · €84k
Income taxes
€84k▲
2024 · €72k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€953k€1.03M▲
Fixed assets21/28€313k€292k▼
Tangible fixed assets22/27€313k€292k▼
Land and buildings22€226k€198k▼
Plant, machinery and equipment23€13k€15k▲
Furniture and vehicles24€49k€60k▲
Other tangible fixed assets26€24k€19k▼
Current assets29/58€640k€738k▲
Amounts receivable within one year40/41€15k€12k▼
Trade receivables40€2k-
Other amounts receivable41€12k€12k▲
Current investments50/53€362k€388k▲
Cash at bank and in hand54/58€251k€325k▲
Deferred charges and accrued income490/1€12k€12k▲
Equity and liabilities
Total equity and liabilities10/49€953k€1.03M▲
Equity10/15€827k€937k▲
Contributions10/11€12k€12k=
Reserves13€814k€924k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€812k€922k▲
Profit (loss) carried forward14€567€567=
Amounts payable17/49€126k€92k▼
Amounts payable after more than one year17€84k€49k▼
Financial debts170/4€84k€49k▼
Amounts payable within one year42/48€42k€44k▲
Current portion of amounts payable after more than one year42€34k€35k▲
Trade debts44€601€77▼
Suppliers440/4€601€77▼
Taxes, remuneration and social security45€4k€6k▲
Taxes450/3€4k€6k▲
Other amounts payable47/48€3k€2k▼
Accrued charges and deferred income492/3€16-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€51k€53k▲
Other operating charges640/8€5k€6k▲
Gross operating margin9900€301k€310k▲
Operating profit (loss)9901€245k€252k▲
Financial income75/76B€14k€28k▲
Recurring financial income75€14k€28k▲
Financial charges65/66B€19k€5k▼
Recurring financial charges65€19k€5k▼
Profit (loss) for the period before taxes9903€239k€275k▲
Income taxes67/77€72k€84k▲
Profit (loss) for the period9904€167k€190k▲
Profit (loss) for the period to be appropriated9905€167k€190k▲
Appropriation of the result
Profit (loss) to be appropriated9906€167k€191k▲
Profit (loss) brought forward from the previous period14P€567€567=
Transfer from equity791/2€83k€80k▼
Transfer to equity691/2€167k€190k▲
To other reserves6921€167k€190k▲
Profit to be distributed694/7€83k€80k▼
Return on contributions (dividend)694€83k€80k▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2018net €190k ▲14.2%
Operating result €252k, net result €190k, both a record.
04-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 35 days late
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Equity above €500kEq €578k ▲29.8%
4 profitable years in a row build equity to €578k.
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 92 days late
2019
31-12
Financial
Weakest financial yearnet €80k ▼3.1%
Net result drops to €80k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 4.97
Current ratio from 2.27 to 4.97; short-term debt falls from €63k to €51k.
31-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 31 days late
2018
24-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 24 days late
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 2 establishment units since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Westergemstraat 1839032 GentGround area
1,213 m²
Building footprint
446 m²
Volume, LiDAR
2,475 m³
2 parcels, Flanders · tallest building 11.3 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Westergemstraat 183, 9032 Gent
since 20102.195.267.673
Dr. Jeroen Claeys - Huisarts
since 20132.224.170.408
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44074B0494/00L002 | Flanders | 958 m² | 1 · 195 m² | 6.4 m · 2 fl. |
| 44816K0530/00F005 | Flanders | 254 m² | 1 · 251 m² | 11.3 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 1,298 EUR awarded · 1,298 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 1,298 EUR | 1,298 EUR |
Schemes
Retroactieve investeringspremie voor eigenaars van zonnepanelen na afschaffing van terugdraaiende teller
Similar companies · same sector, comparable size
Dr. Jan Wynsberghe
BE 0632.654.388
Brugge · Eq €938k
Dokter Bruno Jansen
BE 0822.974.130
Tienen · Eq €936k
Dr Petra Van Landeghem, huisarts
BE 0811.611.866
Beveren-Kruibeke-Zwijndrecht · Eq €938k
MEDICE
BE 0821.885.255
Rotselaar · Eq €936k
Maison Médicale Le Brasero
BE 0650.947.796
Verviers · Eq €939k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,163 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-12-2010
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.